Template:AHA SAH BP Guidelines
Revision as of 02:11, 18 January 2026 by Ostermayer (talk | contribs) (Marked this version for translation)
AHA Aneurysmal SAH BP Guidelines[1]
- No well-controlled studies exist that answer whether BP control influences rebleeding
- BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).
- Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)
